{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T03:32:13Z","timestamp":1770780733015,"version":"3.50.0"},"reference-count":25,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Botulinum toxin (BT) is an effective treatment for spasticity symptoms in multiple sclerosis (MS). Despite its wide use in clinical practices, only few studies have explored long-term persistence. We aim to evaluate the rate of discontinuation of BT treatment and the correlation with MS, spasticity, and injection variables. This retrospective study on 3-year prospectively collected data included 122 MS patients receiving BT injections for spasticity. We collected MS clinical variables (disease durations, Expanded Disability Status Scales [EDSSs], disease-modifying treatments [DMT], and Symbol Digit Modalities Tests [SDMTs]), modified Ashworth scales [MASs], concomitant treatments, and injection variables (formulation, dose, number of injections, and intervals between injections). A total of 14 out of the 122 patients discontinued BT after a mean time of 3.0 \u00b1 1.5 years. In the Cox regression model including the MS clinical variables, the probability of BT discontinuations increased in patients with DMT changes during follow-ups (HR = 6.34; 95%Cl = 2.47, 18.08; p &lt; 0.01) and with impaired SDMTs (HR = 1.20; 95%Cl = 1.04, 1.96; p &lt; 0.01). In the model including the spasticity variables, there were no associations between BT discontinuation and MAS or other spasticity treatments. In the model including the injection variables, the probability of discontinuation decreased by 80% for each cumulative injection (HR = 0.16; 95%Cl = 0.05, 0.45; p &lt; 0.01), but increased by 1% for each additional day over the 3-month interval between injections (HR = 1.27; 95%Cl = 1.07, 1.83; p &lt; 0.01). BT discontinuation was associated with concomitant MS-related issues (e.g., treatment failure and DMT change) and the presence of cognitive impairment, which should be accounted for when planning injections. The interval between injections should be kept as short as possible from regulatory and clinical perspectives to maximize the response across all of the spasticity symptoms and to reduce discontinuation in the long term.<\/jats:p>","DOI":"10.3390\/toxins14110774","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T02:11:15Z","timestamp":1668046275000},"page":"774","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis"],"prefix":"10.3390","volume":"14","author":[{"given":"Federica","family":"Novarella","sequence":"first","affiliation":[{"name":"Multiple Sclerosis Clinical Care Unit, Federico II University Hospital, 80131 Naples, Italy"},{"name":"Department of Neurosciences, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1574-9693","authenticated-orcid":false,"given":"Antonio","family":"Carotenuto","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Clinical Care Unit, Federico II University Hospital, 80131 Naples, Italy"},{"name":"Department of Neurosciences, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Cipullo","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Iodice","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Clinical Care Unit, Federico II University Hospital, 80131 Naples, Italy"},{"name":"Department of Neurosciences, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0728-2640","authenticated-orcid":false,"given":"Emanuele","family":"Cassano","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Clinical Care Unit, Federico II University Hospital, 80131 Naples, Italy"},{"name":"Department of Neurosciences, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3287-3247","authenticated-orcid":false,"given":"Antonio Luca","family":"Spiezia","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Clinical Care Unit, Federico II University Hospital, 80131 Naples, Italy"},{"name":"Department of Neurosciences, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Capasso","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Clinical Care Unit, Federico II University Hospital, 80131 Naples, Italy"},{"name":"Department of Neurosciences, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Petracca","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Clinical Care Unit, Federico II University Hospital, 80131 Naples, Italy"},{"name":"Department of Neurosciences, Federico II University of Naples, 80131 Naples, Italy"},{"name":"Department of Human Neurosciences, Sapienza University of Rome, 00185 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizia","family":"Falco","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmine","family":"Iacovazzo","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Servillo","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6388-8180","authenticated-orcid":false,"given":"Roberta","family":"Lanzillo","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Clinical Care Unit, Federico II University Hospital, 80131 Naples, Italy"},{"name":"Department of Neurosciences, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Brescia Morra","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Clinical Care Unit, Federico II University Hospital, 80131 Naples, Italy"},{"name":"Department of Neurosciences, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2613-3090","authenticated-orcid":false,"given":"Marcello","family":"Moccia","sequence":"additional","affiliation":[{"name":"Multiple Sclerosis Clinical Care Unit, Federico II University Hospital, 80131 Naples, Italy"},{"name":"Department of Molecular Medicine and Medical Biotechnology, Federico II University of Naples, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s40271-016-0173-0","article-title":"A Cross-Sectional Study of the Impact of Spasticity on Daily Activities in Multiple Sclerosis","volume":"9","author":"Bethoux","year":"2016","journal-title":"Patient Patient-Centered Outcomes Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"802918","DOI":"10.3389\/fneur.2021.802918","article-title":"Theoretical and Therapeutic Implications of the Spasticity-Plus Syndrome Model in Multiple Sclerosis","volume":"12","author":"Bruno","year":"2022","journal-title":"Front. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1007\/s10072-020-04392-8","article-title":"Botulinum toxin for the management of spasticity in multiple sclerosis: The Italian botulinum toxin network study","volume":"41","author":"Moccia","year":"2020","journal-title":"Neurol. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1007\/s10072-021-05182-6","article-title":"Nabiximols and botulinum toxin injections for patients with multiple sclerosis: Efficacy on spasticity and spasms in a single-centre experience","volume":"42","author":"Sartori","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/10749357.2016.1139294","article-title":"Effectiveness of Botulinum Toxin for Lower Limbs Spasticity after Stroke: A Systematic Review and Meta-Analysis","volume":"23","author":"Wu","year":"2015","journal-title":"Top. Stroke Rehabilitation"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Intiso, D., Simone, V., Bartolo, M., Santamato, A., Ranieri, M., Gatta, M.T., and Di Rienzo, F. (2020). High Dosage of Botulinum Toxin Type A in Adult Subjects with Spasticity Following Acquired Central Nervous System Damage: Where Are We at?. Toxins, 12.","DOI":"10.3390\/toxins12050315"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Lannin, N.A., Ada, L., English, C., Ratcliffe, J., Faux, S., Palit, M., Gonzalez, S., Olver, J., Schneider, E., and Crotty, M. (2022). Long-term effect of additional rehabilitation following botulinum toxin-A on upper limb activity in chronic stroke: The InTENSE randomised trial. BMC Neurol., 22.","DOI":"10.1186\/s12883-022-02672-8"},{"key":"ref_8","first-page":"521","article-title":"Spasticity treatment with onabotulinumtoxin A: Data from a prospective German real-life patient registry","volume":"121","author":"Schramm","year":"2014","journal-title":"J. Neural Transm."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1212\/WNL.0000000000004687","article-title":"Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension","volume":"89","author":"Gracies","year":"2017","journal-title":"Neurology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/s00415-018-8831-x","article-title":"A multicentRE observational analysiS of PErsistenCe to Treatment in the new multiple sclerosis era: The RESPECT study","volume":"265","author":"Lanzillo","year":"2018","journal-title":"J. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Moccia, M., Loperto, I., Lanzillo, R., Capacchione, A., Carotenuto, A., Triassi, M., Morra, V.B., and Palladino, R. (2020). Persistence, adherence, healthcare resource utilisation and costs for interferon Beta in multiple sclerosis: A population-based study in the Campania region (southern Italy). BMC Health Serv. Res., 20.","DOI":"10.1186\/s12913-020-05664-x"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s10072-017-3078-3","article-title":"Determinants of botulinum toxin discontinuation in multiple sclerosis: A retrospective study","volume":"38","author":"Latino","year":"2017","journal-title":"Neurol. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hara, T., Abo, M., Hara, H., Sasaki, N., Yamada, N., Niimi, M., and Shimamoto, Y. (2018). The Effect of Repeated Botulinum Toxin A Therapy Combined with Intensive Rehabilitation on Lower Limb Spasticity in Post-Stroke Patients. Toxins, 10.","DOI":"10.3390\/toxins10090349"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1007\/s10072-021-05553-z","article-title":"The clinical and paraclinical correlates of employment status in multiple sclerosis","volume":"43","author":"Srpova","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mehy.2017.03.011","article-title":"Do flexible inter-injection intervals improve the effects of botulinum toxin A treatment in reducing impairment and disability in patients with spasticity?","volume":"102","author":"Trompetto","year":"2017","journal-title":"Med. Hypotheses"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Baccouche, I., Bensmail, D., Leblong, E., Fraudet, B., Aymard, C., Quintaine, V., Pottier, S., Lansaman, T., Malot, C., and Gallien, P. (2022). Goal-Setting in Multiple Sclerosis-Related Spasticity Treated with Botulinum Toxin: The GASEPTOX Study. Toxins, 14.","DOI":"10.3390\/toxins14090582"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.3390\/toxins7114645","article-title":"Questionnaire about the Adverse Events and Side Effects Following Botulinum Toxin A Treatment in Patients with Cerebral Palsy","volume":"7","author":"Blaszczyk","year":"2015","journal-title":"Toxins"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Cinone, N., Santoro, L., Spina, S., Facciorusso, S., Battaglia, M., Baricich, A., Marcogiuseppe, P., and Santamato, A. (2022). Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity: A 10-Year Retrospective Analysis. Toxins, 14.","DOI":"10.3390\/toxins14100675"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1177\/1352458515599075","article-title":"Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression","volume":"22","author":"Moccia","year":"2016","journal-title":"Mult. Scler."},{"key":"ref_21","first-page":"1289","article-title":"The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests","volume":"23","author":"Costabile","year":"2016","journal-title":"Mult. Scler. J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1093\/brain\/awv258","article-title":"Defining reliable disability outcomes in multiple sclerosis","volume":"138","author":"Kalincik","year":"2015","journal-title":"Brain"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.rehab.2018.10.004","article-title":"The neurophysiology of deforming spastic paresis: A revised taxonomy","volume":"62","author":"Baude","year":"2018","journal-title":"Ann. Phys. Rehabilitation Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/ene.14110","article-title":"Italian consensus on treatment of spasticity in multiple sclerosis","volume":"27","author":"Comi","year":"2019","journal-title":"Eur. J. Neurol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1212\/WNL.0000000000006688","article-title":"High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapy","volume":"92","author":"Albrecht","year":"2019","journal-title":"Neurology"}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/14\/11\/774\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:13:30Z","timestamp":1760145210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/14\/11\/774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,9]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["toxins14110774"],"URL":"https:\/\/doi.org\/10.3390\/toxins14110774","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,9]]}}}